INFLAMATORY BOWEL DISEASE
Clinical trials for INFLAMATORY BOWEL DISEASE explained in plain language.
Never miss a new study
Get alerted when new INFLAMATORY BOWEL DISEASE trials appear
Sign up with your email to follow new studies for INFLAMATORY BOWEL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Crohn's patients: drug switch shows promise
Disease control Recruiting nowThis study looks at whether a drug called guselkumab can help people with moderate to severe Crohn's disease who did not get better with or could not tolerate another drug called ustekinumab. About 60 adults will take guselkumab for a year, and researchers will check if their sym…
Matched conditions: INFLAMATORY BOWEL DISEASE
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 26, 2026 03:32 UTC
-
New combo therapy offers hope for stubborn IBD cases
Disease control Recruiting nowThis study tests whether combining two drugs—guselkumab and a JAK inhibitor—can help people with inflammatory bowel disease (IBD) that hasn't improved with other treatments. About 80 participants with moderate to severe IBD will receive the combination and be followed for up to 5…
Matched conditions: INFLAMATORY BOWEL DISEASE
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New scan could spot hidden scarring in Crohn's patients before It's too late
Diagnosis Recruiting nowThis study tests whether a special PET scan can find early scarring in the small bowel of people with Crohn's disease. About 45 adults with Crohn's will get the scan, and researchers will compare those with known strictures to those without. The goal is to see if the scan can det…
Matched conditions: INFLAMATORY BOWEL DISEASE
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 18, 2026 12:04 UTC
-
New model aims to end guesswork in IBD treatment
Knowledge-focused Recruiting nowThis study aims to create a reliable way to predict whether a person with inflammatory bowel disease (IBD) will respond to expensive biologic drugs. Researchers will collect data from 200 patients, including symptoms and lab results, and use machine learning to build a prediction…
Matched conditions: INFLAMATORY BOWEL DISEASE
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:36 UTC